ofloxacin has been researched along with Chlamydia Infections in 85 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Chlamydia Infections: Infections with bacteria of the genus CHLAMYDIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical efficacy and safety of levofloxacin (LVFX) 500mg qd were evaluated in female patients with cervicitis with Chlamydia trachomatis and intrauterine infections." | 9.15 | [Clinical study of levofloxacin 500 mg qd in the treatment of cervicitis and intrauterine infections caused by Chlamydia trachomatis]. ( Ando, Y; Fujiwara, M; Hoshina, S; Izumi, K; Kinoshita, C; Kurashima, M; Mikamo, H; Nakabe, K; Takahashi, K; Yamagishi, Y; Yoshimura, M; Yoshioka, M, 2011) |
| " Patients identified with laparoscopic findings of salpingitis were treated with 400 mg of intravenous ofloxacin every 12 hours followed by 400 mg of oral ofloxacin every 12 hours for 10 to 14 days." | 9.09 | Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis). ( Kahn, J; Peipert, JF; Rielly-Gauvin, K; Sweet, RL; Walker, CK, 1999) |
| "An investigation was carried out to determine the therapeutic effect of levofloxacin (LVFX) once-a-day oral therapy at the dose of 200 mg/day for 7 days on uterine cervicitis, in comparison with LVFX twice-a-day oral therapy at the dose of 200 mg/day for 7 days." | 9.09 | [Effects of levofloxacin once-a-day therapy on uterine cervicitis]. ( Hayasaki, Y; Ito, K; Izumi, K; Kawazoe, K; Mikamo, H; Sato, Y; Tamaya, T; Yamada, Y, 1999) |
| "Comparison of efficacy and safety of sparfloxacin vs ofloxacin for treatment of acute bacterial exacerbations of chronic bronchitis (ABECB)." | 9.08 | Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. ( Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D, 1998) |
| "A multicenter randomized comparative trial was done to assess the safety and efficacy of oral ofloxacin (400 mg twice daily for 10 days) versus cefoxitin (2 g intramuscularly) followed by doxycycline (100 mg twice daily orally for 10 days) for the outpatient treatment of uncomplicated pelvic inflammatory disease (PID)." | 9.07 | Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group. ( Berkeley, A; Binder, D; Faro, S; Gordon, S; Martens, MG; Yarborough, DR, 1993) |
| "The object of this randomized study was to compare the safety and efficacy of oral ofloxacin, 400 mg twice daily for 10 days, versus intramuscular cefoxitin, 2 gm, plus oral probenecid, 1 gm, followed by oral doxycycline, 100 mg twice daily for 10 days, in the outpatient treatment of uncomplicated acute salpingitis." | 9.07 | A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. ( Bawdon, RE; Cox, SM; Heard, MC; Nobles, BJ; Theriot, SK; Wendel, GD, 1991) |
| "The efficacy of ofloxacin was compared with that of doxycycline in the treatment of non-gonococcal urethritis (NGU) and cervical chlamydial infection in an open randomized study." | 9.06 | Comparison of ofloxacin with doxycycline in the treatment of non-gonococcal urethritis and cervical chlamydial infection. ( Donegan, C; Harris, JR; Kitchen, VS; Taylor-Robinson, D; Thomas, B; Ward, H, 1990) |
| "Efficacy and safety of ofloxacin (OFLX), a new quinolone antibacterial agent, were investigated in cases of sexually transmitted male urethritis and cervicitis." | 9.06 | [Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis]. ( Aso, Y; Higashihara, E; Hirose, T; Kishi, H; Kiyota, H; Kumamoto, Y; Machida, T; Okazaki, T; Sakai, S; Tsunekawa, T, 1988) |
| " trachomatis urethritis were treated for five days with 2 X 200 mg ofloxacin." | 9.06 | Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis. ( Bischoff, W, 1986) |
| "Fifty-eight males and 34 females with nongonococcal urethritis and/or cervicitis were treated to compare the efficacy and safety of 7-day regimens of oral ofloxacin 300 mg twice daily and doxycycline hyclate 100 mg twice daily." | 9.06 | Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis. ( Beville, R; Holmes, B; Lutz, FB; Mogabgab, WJ; Murray, M; Tack, KJ, 1990) |
| "Limited data suggest that tetracycline or erythromycin is the antibiotic of choice for treating Chlamydia pneumoniae infection, but they are not always effective or well tolerated." | 9.06 | Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections. ( Grayston, JT; Kuo, CC; Lipsky, BA; Tack, KJ; Wang, SP, 1990) |
| "We investigated the efficacy and safety of levofloxacin (LVFX) 500mg once a day in patients with non-gonorrheal urethritis." | 7.78 | [Efficacy and safety of levofloxacin to non-gonorrheal urethritis]. ( Hosobe, T; Kato, T; Onodera, S; Onoe, Y; Yoshida, M, 2012) |
| "To confirm the efficacy of the treatment regimen with oral levofloxacin (LVFX) 500 mg once daily for 7 days for patients with non-gonococcal urethritis (NGU), we evaluated the microbiological and clinical outcomes of the regimen in those patients." | 7.77 | Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. ( Hashimoto, J; Hayashi, K; Ichihara, K; Iwasawa, A; Kurimura, Y; Satoh, T; Sunaoshi, K; Suzuki, N; Takahashi, S; Takeda, K; Tsukamoto, T, 2011) |
| " The effects of levofloxacin administration at a dose of 300 mg/day for 5-14 days were investigated in the subjects (n = 66) after the discussion of cystic cervicitis." | 7.69 | [Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection]. ( Chimura, T, 1997) |
| "We attempted to define the microbiologic characteristics of acute salpingitis in women presenting to an urban emergency department with pelvic inflammatory disease and to determine the effectiveness of ofloxacin in treating this disease." | 7.68 | Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. ( Brockwell, NJ; Dalton, HP; Soper, DE, 1992) |
| "Clinical effects of ofloxacin (OFLX) in the treatment of the patients with chlamydial urethritis was studied." | 7.67 | [Treatment of chlamydial urethritis--studies on clinical effects of ofloxacin]. ( Asano, H; Fujita, T; Hasegawa, S; Hattori, R; Hibi, H; Kinukawa, T; Matsui, M; Matuura, O; Ohshima, S; Takeuchi, N, 1989) |
| "The efficacy of ofloxacin was evaluated in 30 men with non-gonococcal urethritis (NGU) and 17 women with Chlamydia trachomatis infection of the cervix." | 7.67 | Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women. ( Nayagam, AT; Oriel, JD; Ridgway, GL, 1988) |
| "Ofloxacin is a new fluoroquinolone with in vitro activity against the three main urethritis-causing pathogens: i." | 7.67 | [Treatment with ofloxacin (RU 43280) of uncomplicated bacterial urethritis in males]. ( Bianchi, A; Casin, I; Dolivo, M; Morel, P; Perol, Y, 1986) |
| "The effect of Ofloxacin administered orally 600 mg everyday for 14 days was evaluated in 20 male patients with Chlamydial urethritis, in whom Chlamydia was identified from urethral secretion by immunohistochemical technique using monoclonal primary antibody specific for all known serotypes of Chlamydia trachomatis and psittaci." | 7.67 | [Ofloxacin for the treatment of chlamydial urethritis]. ( Araki, H; Azuma, Y; Kitamori, T; Terasaki, T; Watanabe, H; Yuri, K, 1988) |
| "A multi-institutional clinical study was performed on the efficacy of Ofloxacin against chlamydial urethritis in males between January and June, 1987." | 7.67 | [Studies of clinical efficacy of ofloxacin against male urethritis caused by Chlamydia trachomatis]. ( Matsuda, T; Okada, K; Yoshida, O, 1988) |
| "10 cases of bacterial vaginosis were found and 35 pathogens (E." | 6.74 | Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study. ( Judlin, P; Thiebaugeorges, O, 2009) |
| " In a multicenter study in seven Asian countries, 105 mal patients with chlamydial urethritis and 46 male patients with nongonococcal and nonchlamydial urethritis were treated with oral ofloxacin at a dosage of 200 mg twice daily for 5 to 10 days." | 6.67 | Ofloxacin treatment of nongonococcal urethritis. A multi-center study in Asia. ( Chang, LS; Daili, SF; Kawada, Y; Lai, C; Lee, JM; Limson, BM; Polnikorn, N; Saito, I, 1990) |
| "Sexually transmitted diseases are an important cause of morbidity in women." | 6.38 | The clinical experience with ofloxacin in the treatment of sexually transmitted diseases. ( Corrado, ML, 1991) |
| "The clinical efficacy and safety of levofloxacin (LVFX) 500mg qd were evaluated in female patients with cervicitis with Chlamydia trachomatis and intrauterine infections." | 5.15 | [Clinical study of levofloxacin 500 mg qd in the treatment of cervicitis and intrauterine infections caused by Chlamydia trachomatis]. ( Ando, Y; Fujiwara, M; Hoshina, S; Izumi, K; Kinoshita, C; Kurashima, M; Mikamo, H; Nakabe, K; Takahashi, K; Yamagishi, Y; Yoshimura, M; Yoshioka, M, 2011) |
| " Patients identified with laparoscopic findings of salpingitis were treated with 400 mg of intravenous ofloxacin every 12 hours followed by 400 mg of oral ofloxacin every 12 hours for 10 to 14 days." | 5.09 | Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis). ( Kahn, J; Peipert, JF; Rielly-Gauvin, K; Sweet, RL; Walker, CK, 1999) |
| "An investigation was carried out to determine the therapeutic effect of levofloxacin (LVFX) once-a-day oral therapy at the dose of 200 mg/day for 7 days on uterine cervicitis, in comparison with LVFX twice-a-day oral therapy at the dose of 200 mg/day for 7 days." | 5.09 | [Effects of levofloxacin once-a-day therapy on uterine cervicitis]. ( Hayasaki, Y; Ito, K; Izumi, K; Kawazoe, K; Mikamo, H; Sato, Y; Tamaya, T; Yamada, Y, 1999) |
| "Comparison of efficacy and safety of sparfloxacin vs ofloxacin for treatment of acute bacterial exacerbations of chronic bronchitis (ABECB)." | 5.08 | Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. ( Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D, 1998) |
| "To assess the safety and efficacy of a ten-day oral course of ofloxacin (400 mg 12 hourly) as compared with erythromycin (400 mg every 6 hours) for treatment of lower respiratory tract infections, fifty-two adult outpatients with pulmonary infiltrates (pneumonia) or with a cough and purulent sputum (bronchitis) were evaluated." | 5.07 | Treatment of lower respiratory infections in outpatients with ofloxacin compared with erythromycin. ( Hooton, TM; Lipsky, BA; Pecoraro, RE; Peugeot, RL, 1991) |
| "The object of this randomized study was to compare the safety and efficacy of oral ofloxacin, 400 mg twice daily for 10 days, versus intramuscular cefoxitin, 2 gm, plus oral probenecid, 1 gm, followed by oral doxycycline, 100 mg twice daily for 10 days, in the outpatient treatment of uncomplicated acute salpingitis." | 5.07 | A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. ( Bawdon, RE; Cox, SM; Heard, MC; Nobles, BJ; Theriot, SK; Wendel, GD, 1991) |
| "A multicenter randomized comparative trial was done to assess the safety and efficacy of oral ofloxacin (400 mg twice daily for 10 days) versus cefoxitin (2 g intramuscularly) followed by doxycycline (100 mg twice daily orally for 10 days) for the outpatient treatment of uncomplicated pelvic inflammatory disease (PID)." | 5.07 | Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group. ( Berkeley, A; Binder, D; Faro, S; Gordon, S; Martens, MG; Yarborough, DR, 1993) |
| "Limited data suggest that tetracycline or erythromycin is the antibiotic of choice for treating Chlamydia pneumoniae infection, but they are not always effective or well tolerated." | 5.06 | Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections. ( Grayston, JT; Kuo, CC; Lipsky, BA; Tack, KJ; Wang, SP, 1990) |
| "The efficacy of ofloxacin was compared with that of doxycycline in the treatment of non-gonococcal urethritis (NGU) and cervical chlamydial infection in an open randomized study." | 5.06 | Comparison of ofloxacin with doxycycline in the treatment of non-gonococcal urethritis and cervical chlamydial infection. ( Donegan, C; Harris, JR; Kitchen, VS; Taylor-Robinson, D; Thomas, B; Ward, H, 1990) |
| "Fifty-eight males and 34 females with nongonococcal urethritis and/or cervicitis were treated to compare the efficacy and safety of 7-day regimens of oral ofloxacin 300 mg twice daily and doxycycline hyclate 100 mg twice daily." | 5.06 | Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis. ( Beville, R; Holmes, B; Lutz, FB; Mogabgab, WJ; Murray, M; Tack, KJ, 1990) |
| "This study compared doxycycline with ofloxacin in the treatment of nongonococcal urethritis in men and mucopurulent cervicitis in women and compared both drugs in the treatment of infections due to Chlamydia trachomatis in both men and women." | 5.06 | Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease. ( Batteiger, BE; Jones, RB; White, A, 1989) |
| "Efficacy and safety of ofloxacin (OFLX), a new quinolone antibacterial agent, were investigated in cases of sexually transmitted male urethritis and cervicitis." | 5.06 | [Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis]. ( Aso, Y; Higashihara, E; Hirose, T; Kishi, H; Kiyota, H; Kumamoto, Y; Machida, T; Okazaki, T; Sakai, S; Tsunekawa, T, 1988) |
| "Experience with ofloxacin in the United States in the treatment of sexually transmitted diseases is reviewed." | 5.06 | Clinical experience with ofloxacin in sexually transmitted disease. ( Beals, BS; Judson, FN; Tack, KJ, 1986) |
| " trachomatis urethritis were treated for five days with 2 X 200 mg ofloxacin." | 5.06 | Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis. ( Bischoff, W, 1986) |
| "We investigated the efficacy and safety of levofloxacin (LVFX) 500mg once a day in patients with non-gonorrheal urethritis." | 3.78 | [Efficacy and safety of levofloxacin to non-gonorrheal urethritis]. ( Hosobe, T; Kato, T; Onodera, S; Onoe, Y; Yoshida, M, 2012) |
| "To confirm the efficacy of the treatment regimen with oral levofloxacin (LVFX) 500 mg once daily for 7 days for patients with non-gonococcal urethritis (NGU), we evaluated the microbiological and clinical outcomes of the regimen in those patients." | 3.77 | Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. ( Hashimoto, J; Hayashi, K; Ichihara, K; Iwasawa, A; Kurimura, Y; Satoh, T; Sunaoshi, K; Suzuki, N; Takahashi, S; Takeda, K; Tsukamoto, T, 2011) |
| " A few days before he had been treated with ciprofloxacine 500mg bid for chlamydial urethritis." | 3.74 | [Fluorquinolone associated tendon rupture]. ( Bürr, P; Haschke, M; Rätz Bravo, A; Stoll, R, 2008) |
| " We report a case of serious systemic CP infection with capillary leak syndrome and cutaneus vasculitis who was treated successfully with levofloxacin." | 3.71 | [Multisystemic severe infection with Chlamydia pneumoniae]. ( Clark, G; Perroud, N; Reusser, P, 2002) |
| " The effects of levofloxacin administration at a dose of 300 mg/day for 5-14 days were investigated in the subjects (n = 66) after the discussion of cystic cervicitis." | 3.69 | [Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection]. ( Chimura, T, 1997) |
| "We attempted to define the microbiologic characteristics of acute salpingitis in women presenting to an urban emergency department with pelvic inflammatory disease and to determine the effectiveness of ofloxacin in treating this disease." | 3.68 | Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. ( Brockwell, NJ; Dalton, HP; Soper, DE, 1992) |
| "Clinical effects of ofloxacin (OFLX) in the treatment of the patients with chlamydial urethritis was studied." | 3.67 | [Treatment of chlamydial urethritis--studies on clinical effects of ofloxacin]. ( Asano, H; Fujita, T; Hasegawa, S; Hattori, R; Hibi, H; Kinukawa, T; Matsui, M; Matuura, O; Ohshima, S; Takeuchi, N, 1989) |
| "A multi-institutional clinical study was performed on the efficacy of Ofloxacin against chlamydial urethritis in males between January and June, 1987." | 3.67 | [Studies of clinical efficacy of ofloxacin against male urethritis caused by Chlamydia trachomatis]. ( Matsuda, T; Okada, K; Yoshida, O, 1988) |
| "The efficacy of ofloxacin was evaluated in 30 men with non-gonococcal urethritis (NGU) and 17 women with Chlamydia trachomatis infection of the cervix." | 3.67 | Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women. ( Nayagam, AT; Oriel, JD; Ridgway, GL, 1988) |
| "The effect of Ofloxacin administered orally 600 mg everyday for 14 days was evaluated in 20 male patients with Chlamydial urethritis, in whom Chlamydia was identified from urethral secretion by immunohistochemical technique using monoclonal primary antibody specific for all known serotypes of Chlamydia trachomatis and psittaci." | 3.67 | [Ofloxacin for the treatment of chlamydial urethritis]. ( Araki, H; Azuma, Y; Kitamori, T; Terasaki, T; Watanabe, H; Yuri, K, 1988) |
| "Ofloxacin is a new fluoroquinolone with in vitro activity against the three main urethritis-causing pathogens: i." | 3.67 | [Treatment with ofloxacin (RU 43280) of uncomplicated bacterial urethritis in males]. ( Bianchi, A; Casin, I; Dolivo, M; Morel, P; Perol, Y, 1986) |
| "10 cases of bacterial vaginosis were found and 35 pathogens (E." | 2.74 | Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study. ( Judlin, P; Thiebaugeorges, O, 2009) |
| "pneumoniae IgA and/or IgG." | 2.73 | Effect on carotid atherosclerosis of probucol plus levofloxacin for Chlamydia pneumoniae infection. ( Furusyo, N; Hayashi, J; Kikuchi, K; Maeda, S; Ohnishi, H; Sawayama, Y; Tatsukawa, M, 2007) |
| "30." | 2.68 | [Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections]. ( Badonnel, Y; Dailloux, M; Judlin, P; Koebele, A; Landes, P; Pavis, A; van Walleghen, E; Zaccabri, A, 1995) |
| "Ofloxacin was successful in eradicating C." | 2.67 | Effectiveness of ofloxacin in the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae cervical infection. ( Faro, S; Hammill, HA; Maccato, M; Martens, MG; Riddle, G; Roberts, S, 1991) |
| " In a multicenter study in seven Asian countries, 105 mal patients with chlamydial urethritis and 46 male patients with nongonococcal and nonchlamydial urethritis were treated with oral ofloxacin at a dosage of 200 mg twice daily for 5 to 10 days." | 2.67 | Ofloxacin treatment of nongonococcal urethritis. A multi-center study in Asia. ( Chang, LS; Daili, SF; Kawada, Y; Lai, C; Lee, JM; Limson, BM; Polnikorn, N; Saito, I, 1990) |
| "Gonorrhea, trichomoniasis, chlamydiosis and Ureaplasma infection were detected in 60, 31." | 2.67 | [Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases]. ( Bakalova, LA; Bednova, VN; Bugrov, AV; Kisina, VI; Navolotskaia, TI; Vakhnina, TE, 1992) |
| "Sexually transmitted diseases are an important cause of morbidity in women." | 2.38 | The clinical experience with ofloxacin in the treatment of sexually transmitted diseases. ( Corrado, ML, 1991) |
| "Most patients (81%) with pelvic inflammatory disease were diagnosed as having chlamydia alone." | 1.48 | Gonococcal and Chlamydial Cases of Pelvic Inflammatory Disease at 2 Canadian Sexually Transmitted Infection Clinics, 2004 to 2014: A Retrospective Cross-sectional Review. ( Chen, JZ; Gratrix, J; Parker, P; Read, R; Singh, AE; Smyczek, P, 2018) |
| "Acute epididymitis is increasing in men aged 35 years or under due to sexually-transmitted Chlamydia trachomatis." | 1.32 | Management of acute epididymitis: are European guidelines being followed? ( Adamson, AS; Breitenfeldt, N; Drury, NE; Dyer, JP; Harrison, GS, 2004) |
| "Ofloxacin was used to treat patients with gonorrhoea and/or Chlamydia trachomatis infection." | 1.27 | The efficacy of ofloxacin against infection caused by Neisseria gonorrhoeae and Chlamydia trachomatis. ( Bhattacharyya, MN; Chowdhury, FH; Maiti, H; Richmond, SJ; Stirland, RM; Tooth, JA, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (24.71) | 18.7374 |
| 1990's | 31 (36.47) | 18.2507 |
| 2000's | 24 (28.24) | 29.6817 |
| 2010's | 9 (10.59) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JZ | 1 |
| Gratrix, J | 1 |
| Smyczek, P | 1 |
| Parker, P | 1 |
| Read, R | 1 |
| Singh, AE | 1 |
| Páez-Canro, C | 1 |
| Alzate, JP | 1 |
| González, LM | 1 |
| Rubio-Romero, JA | 1 |
| Lethaby, A | 1 |
| Gaitán, HG | 1 |
| Onodera, S | 1 |
| Onoe, Y | 1 |
| Hosobe, T | 1 |
| Kato, T | 1 |
| Yoshida, M | 1 |
| Kuuliala, A | 1 |
| Julkunen, H | 1 |
| Paimela, L | 1 |
| Peltomaa, R | 1 |
| Kautiainen, H | 1 |
| Repo, H | 1 |
| Leirisalo-Repo, M | 1 |
| Dupin, N | 1 |
| Janier, M | 1 |
| Bouscarat, F | 1 |
| Vernay-Vaisse, C | 1 |
| Spenatto, N | 1 |
| Vermersch-Langlin, A | 1 |
| Rätz Bravo, A | 1 |
| Stoll, R | 1 |
| Bürr, P | 1 |
| Haschke, M | 1 |
| Noguchi, Y | 1 |
| Judlin, P | 2 |
| Thiebaugeorges, O | 1 |
| Magri, V | 1 |
| Marras, E | 1 |
| Skerk, V | 1 |
| Markotić, A | 1 |
| Restelli, A | 1 |
| Garlaschi, MC | 1 |
| Perletti, G | 1 |
| Takahashi, S | 1 |
| Ichihara, K | 1 |
| Hashimoto, J | 1 |
| Kurimura, Y | 1 |
| Iwasawa, A | 1 |
| Hayashi, K | 1 |
| Sunaoshi, K | 1 |
| Takeda, K | 1 |
| Suzuki, N | 1 |
| Satoh, T | 1 |
| Tsukamoto, T | 1 |
| Bohbot, JM | 1 |
| Mikamo, H | 3 |
| Yamagishi, Y | 1 |
| Takahashi, K | 1 |
| Izumi, K | 2 |
| Hoshina, S | 1 |
| Nakabe, K | 1 |
| Fujiwara, M | 1 |
| Yoshimura, M | 1 |
| Ando, Y | 1 |
| Kurashima, M | 1 |
| Kinoshita, C | 1 |
| Yoshioka, M | 1 |
| Perroud, N | 1 |
| Clark, G | 1 |
| Reusser, P | 1 |
| Roblin, PM | 5 |
| Reznik, T | 2 |
| Kutlin, A | 1 |
| Hammerschlag, MR | 5 |
| Baltch, AL | 2 |
| Smith, RP | 2 |
| Ritz, WJ | 2 |
| Carpenter-Knaggs, A | 1 |
| Michelsen, PB | 1 |
| Carlyn, CJ | 1 |
| Bopp, LH | 2 |
| Hibbs, JR | 1 |
| Lobzin, IuV | 2 |
| Volzhanin, VM | 1 |
| Pozniak, AL | 1 |
| Kilic, D | 1 |
| Basar, MM | 1 |
| Kaygusuz, S | 1 |
| Yilmaz, E | 1 |
| Basar, H | 1 |
| Batislam, E | 1 |
| Kohlhoff, SA | 1 |
| Hawser, S | 1 |
| Islam, K | 1 |
| Dunbar, LM | 1 |
| Khashab, MM | 1 |
| Kahn, JB | 1 |
| Zadeikis, N | 1 |
| Xiang, JX | 1 |
| Tennenberg, AM | 1 |
| Carpenter, AN | 1 |
| Halse, TA | 1 |
| Drury, NE | 1 |
| Dyer, JP | 1 |
| Breitenfeldt, N | 1 |
| Adamson, AS | 1 |
| Harrison, GS | 1 |
| Komeda, H | 1 |
| Fujimoto, Y | 1 |
| Uno, M | 1 |
| Takada, T | 1 |
| Yamada, Y | 2 |
| Berger, RE | 1 |
| Yokoi, S | 1 |
| Yasuda, M | 1 |
| Ito, S | 1 |
| Takahashi, Y | 1 |
| Ishihara, S | 1 |
| Deguchi, T | 1 |
| Maeda, S | 2 |
| Kubota, Y | 1 |
| Tamaki, M | 1 |
| Fukushi, H | 1 |
| Tamaya, T | 2 |
| Tanaka, K | 1 |
| Watanabe, K | 1 |
| Sawayama, Y | 1 |
| Tatsukawa, M | 1 |
| Kikuchi, K | 1 |
| Ohnishi, H | 1 |
| Furusyo, N | 1 |
| Hayashi, J | 1 |
| Altiparmak, UE | 1 |
| Ozer, PA | 1 |
| Ozkuyumcu, C | 1 |
| Us, AD | 1 |
| Aslan, BS | 1 |
| Duman, S | 1 |
| Koebele, A | 1 |
| Zaccabri, A | 1 |
| van Walleghen, E | 1 |
| Pavis, A | 1 |
| Badonnel, Y | 1 |
| Dailloux, M | 1 |
| Landes, P | 1 |
| Weber, JT | 1 |
| Johnson, RE | 1 |
| Loughlin, KA | 1 |
| Bakst, CM | 1 |
| Rybak, MJ | 1 |
| Kuznetsov, VP | 1 |
| Dubenskiĭ, VV | 1 |
| Delektorskiĭ, VV | 1 |
| Igoshin, IuM | 1 |
| Beliaev, DL | 1 |
| Iashkova, GN | 1 |
| Babaiants, AA | 1 |
| Verhoest, P | 2 |
| Fernandez, H | 1 |
| Henry-Suchet, J | 2 |
| Orfila, J | 2 |
| Boulanger, JC | 2 |
| Tannous, W | 1 |
| Martens, MG | 2 |
| Gordon, S | 1 |
| Yarborough, DR | 1 |
| Faro, S | 2 |
| Binder, D | 1 |
| Berkeley, A | 1 |
| Nedeljkovic, M | 1 |
| Djukic, S | 1 |
| Chimura, T | 2 |
| DeAbate, CA | 1 |
| Henry, D | 1 |
| Bensch, G | 1 |
| Jubran, A | 1 |
| Chodosh, S | 1 |
| Harper, L | 1 |
| Tipping, D | 1 |
| Talbot, GH | 1 |
| Donati, M | 1 |
| Rumpianesi, F | 1 |
| Marchetti, F | 1 |
| Sambri, V | 1 |
| Cevenini, R | 1 |
| Peipert, JF | 1 |
| Sweet, RL | 1 |
| Walker, CK | 1 |
| Kahn, J | 1 |
| Rielly-Gauvin, K | 1 |
| Sato, Y | 1 |
| Hayasaki, Y | 1 |
| Ito, K | 1 |
| Kawazoe, K | 1 |
| Somani, J | 1 |
| Bhullar, VB | 1 |
| Workowski, KA | 1 |
| Farshy, CE | 1 |
| Black, CM | 1 |
| Miyashita, N | 2 |
| Matsumoto, A | 1 |
| Matsushima, T | 2 |
| Niki, Y | 1 |
| Kirchner, JT | 1 |
| Chidiac, C | 1 |
| Senneville, E | 1 |
| Mouton, Y | 1 |
| Bednova, VN | 1 |
| Bakalova, LA | 1 |
| Bugrov, AV | 1 |
| Navolotskaia, TI | 1 |
| Kisina, VI | 1 |
| Vakhnina, TE | 1 |
| Hooton, TM | 2 |
| Batteiger, BE | 2 |
| Judson, FN | 2 |
| Spruance, SL | 1 |
| Stamm, WE | 1 |
| Soper, DE | 1 |
| Brockwell, NJ | 1 |
| Dalton, HP | 1 |
| Peugeot, RL | 1 |
| Lipsky, BA | 2 |
| Pecoraro, RE | 1 |
| Maccato, M | 1 |
| Hammill, HA | 1 |
| Roberts, S | 1 |
| Riddle, G | 1 |
| Wendel, GD | 1 |
| Cox, SM | 1 |
| Bawdon, RE | 1 |
| Theriot, SK | 1 |
| Heard, MC | 1 |
| Nobles, BJ | 1 |
| Corrado, ML | 1 |
| Kawada, Y | 1 |
| Lee, JM | 1 |
| Saito, I | 1 |
| Lai, C | 1 |
| Chang, LS | 1 |
| Limson, BM | 1 |
| Polnikorn, N | 1 |
| Daili, SF | 1 |
| Tack, KJ | 3 |
| Kuo, CC | 1 |
| Wang, SP | 1 |
| Grayston, JT | 1 |
| Kiriushchenkov, AP | 1 |
| Kitchen, VS | 1 |
| Donegan, C | 1 |
| Ward, H | 1 |
| Thomas, B | 1 |
| Harris, JR | 1 |
| Taylor-Robinson, D | 1 |
| Mogabgab, WJ | 1 |
| Holmes, B | 1 |
| Murray, M | 1 |
| Beville, R | 1 |
| Lutz, FB | 1 |
| Jones, RB | 1 |
| White, A | 1 |
| Haider, F | 1 |
| Vitse, M | 1 |
| Black, JR | 1 |
| Long, JM | 1 |
| Zwickl, BE | 1 |
| Ray, BS | 1 |
| Verdon, MS | 1 |
| Wetherby, S | 1 |
| Hook, EW | 1 |
| Handsfield, HH | 1 |
| Asano, H | 1 |
| Hibi, H | 1 |
| Ohshima, S | 1 |
| Kinukawa, T | 1 |
| Matuura, O | 1 |
| Takeuchi, N | 1 |
| Hattori, R | 1 |
| Hasegawa, S | 1 |
| Fujita, T | 1 |
| Matsui, M | 1 |
| Chandeying, V | 1 |
| Sutthijumroon, S | 1 |
| Tungphaisal, S | 1 |
| Blomer, R | 1 |
| Bruch, K | 1 |
| Klose, U | 1 |
| Matsuda, T | 1 |
| Okada, K | 1 |
| Yoshida, O | 1 |
| Kumamoto, Y | 1 |
| Sakai, S | 1 |
| Hirose, T | 1 |
| Tsunekawa, T | 1 |
| Machida, T | 1 |
| Kiyota, H | 1 |
| Okazaki, T | 1 |
| Kishi, H | 1 |
| Higashihara, E | 1 |
| Aso, Y | 1 |
| Hartinger, A | 1 |
| Korting, HC | 1 |
| Neubert, U | 1 |
| Blaufuss, H | 1 |
| Richmond, SJ | 1 |
| Bhattacharyya, MN | 1 |
| Maiti, H | 1 |
| Chowdhury, FH | 1 |
| Stirland, RM | 1 |
| Tooth, JA | 1 |
| Nayagam, AT | 1 |
| Ridgway, GL | 1 |
| Oriel, JD | 1 |
| Yuri, K | 1 |
| Terasaki, T | 1 |
| Kitamori, T | 1 |
| Azuma, Y | 1 |
| Watanabe, H | 1 |
| Araki, H | 1 |
| Matsumura, K | 1 |
| Inoue, S | 2 |
| Shiota, H | 1 |
| Kusujima, K | 1 |
| Mimura, Y | 1 |
| Tamura, O | 1 |
| Abe, M | 1 |
| Fransen, L | 1 |
| Avonts, D | 1 |
| Piot, P | 1 |
| Melekos, MD | 1 |
| Asbach, HW | 1 |
| Morel, P | 1 |
| Casin, I | 1 |
| Bianchi, A | 1 |
| Dolivo, M | 1 |
| Perol, Y | 1 |
| Beals, BS | 1 |
| Bischoff, W | 1 |
6 reviews available for ofloxacin and Chlamydia Infections
| Article | Year |
|---|---|
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women.
Topics: Anti-Bacterial Agents; Asymptomatic Infections; Azithromycin; Chlamydia Infections; Chlamydia tracho | 2019 |
[Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections].
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Cephalosporins; Chlamydia Infection | 2009 |
New treatments for Chlamydia trachomatis genital infection.
Topics: Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Genital Diseases, Fe | 1995 |
Oral treatment of gonorrhea and chlamydia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Chlamydia Infections; Ciprofloxac | 1994 |
[Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
Topics: Anti-Infective Agents; Chlamydia Infections; Ciprofloxacin; Enoxacin; Erythromycin; Humans; In Vitro | 1992 |
The clinical experience with ofloxacin in the treatment of sexually transmitted diseases.
Topics: Chlamydia Infections; Chlamydia trachomatis; Female; Gonorrhea; Humans; Ofloxacin; Pelvic Inflammato | 1991 |
31 trials available for ofloxacin and Chlamydia Infections
| Article | Year |
|---|---|
Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Reactive; Campylobacter Infections; Chlamydia Infections; D | 2013 |
Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Female; Humans; Levofloxacin; Metronidazole; Ofl | 2009 |
[Clinical study of levofloxacin 500 mg qd in the treatment of cervicitis and intrauterine infections caused by Chlamydia trachomatis].
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Dru | 2011 |
Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydophila pneumoniae; Community-Acquired Inf | 2004 |
Effect on carotid atherosclerosis of probucol plus levofloxacin for Chlamydia pneumoniae infection.
Topics: Aged; Anti-Bacterial Agents; Anticholesteremic Agents; Carotid Arteries; Carotid Artery Diseases; Ch | 2007 |
[Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections].
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Chlamydia Infections; | 1995 |
[A new therapeutic strategy using a ofloxacin-amoxicillin-clavulanic acid combination in the treatment of upper gynecologic infections. Apropos of 123 cases].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibito | 1994 |
[Medical management of chronic Chlamydia trachomatis salpingitis resistant to usual antibiotics. Use of ofloxacin alone or combined with other anti-chlamydia antibiotics].
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Chronic Disease; Doxycycline; Drug Resistance, M | 1993 |
Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group.
Topics: Adolescent; Adult; Ambulatory Care; Cefoxitin; Chlamydia Infections; Chlamydia trachomatis; Doxycycl | 1993 |
Ofloxacin. Therapeutic results in Chlamydia trachomatis genital infection.
Topics: Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Female; Fluorescent Antibody Tec | 1995 |
[An attempt to use ofloxacin in the treatment of acute intestinal infections].
Topics: Acute Disease; Anti-Infective Agents; Chlamydia Infections; Drug Resistance, Microbial; Dysentery, B | 1996 |
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamy | 1998 |
Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis).
Topics: Administration, Oral; Adult; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Dru | 1999 |
[Effects of levofloxacin once-a-day therapy on uterine cervicitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Chlamydia Infections; Drug Administration Schedule; | 1999 |
[Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases].
Topics: Chlamydia Infections; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female | 1992 |
Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis.
Topics: Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Humans; Ofloxacin; Random Allocati | 1992 |
Treatment of lower respiratory infections in outpatients with ofloxacin compared with erythromycin.
Topics: Adult; Aged; Bronchitis; Chlamydia Infections; Erythromycin; Female; Humans; Legionnaires' Disease; | 1991 |
Effectiveness of ofloxacin in the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae cervical infection.
Topics: Adolescent; Adult; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Drug Evaluation; Female | 1991 |
A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis.
Topics: Acute Disease; Adult; Ambulatory Care; Cefoxitin; Chi-Square Distribution; Chlamydia Infections; Chl | 1991 |
Ofloxacin treatment of nongonococcal urethritis. A multi-center study in Asia.
Topics: Asia; Chlamydia Infections; Chlamydia trachomatis; Humans; Male; Multicenter Studies as Topic; Oflox | 1990 |
Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections.
Topics: Aged; Bronchitis; Chlamydia; Chlamydia Infections; Clinical Trials as Topic; Drug Resistance, Microb | 1990 |
Comparison of ofloxacin with doxycycline in the treatment of non-gonococcal urethritis and cervical chlamydial infection.
Topics: Adolescent; Adult; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Humans; Male; M | 1990 |
Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis.
Topics: Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Humans; Male; Mycoplasmatales Infe | 1990 |
Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease.
Topics: Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Humans; Male; Ofloxacin; Random Al | 1989 |
[Proposal for a new therapeutic strategy in high genital infections].
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Chlamydia Infections; | 1989 |
Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection.
Topics: Adult; Amoxicillin; Chlamydia Infections; Chlamydia trachomatis; Female; Gonorrhea; Humans; Male; Mi | 1989 |
Evaluation of ofloxacin in the treatment of mucopurulent cervicitis: response of chlamydia-positive and chlamydia-negative forms.
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Dose-Response Relationship, Drug; Female; Humans | 1989 |
[Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis].
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Drug Evaluation; Female; Gonorrhea; Humans; Male | 1988 |
Treatment of genital chlamydial infection with ofloxacin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; | 1986 |
Clinical experience with ofloxacin in sexually transmitted disease.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Clinical Trials as Topic; Double | 1986 |
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Clinical Trials as Topic; | 1986 |
48 other studies available for ofloxacin and Chlamydia Infections
| Article | Year |
|---|---|
Gonococcal and Chlamydial Cases of Pelvic Inflammatory Disease at 2 Canadian Sexually Transmitted Infection Clinics, 2004 to 2014: A Retrospective Cross-sectional Review.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Canada; Chlamydia Infections; | 2018 |
[Efficacy and safety of levofloxacin to non-gonorrheal urethritis].
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Humans; Levofloxacin; Mal | 2012 |
[Chlamydia trachomatis].
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; DNA, Bacterial; Do | 2016 |
[Fluorquinolone associated tendon rupture].
Topics: Achilles Tendon; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Bacte | 2008 |
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Drug Therap | 2010 |
Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Chlamydia Infection | 2011 |
[Chlamydia trachomatis: The enemy of the Fallopian tube].
Topics: Adolescent; Adult; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Fallopian | 2011 |
[Multisystemic severe infection with Chlamydia pneumoniae].
Topics: Adult; Anti-Infective Agents; Capillary Leak Syndrome; Chlamydia Infections; Chlamydophila pneumonia | 2002 |
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Azithromycin; Chlamydia I | 2003 |
Levofloxacin kills Chlamydia pneumoniae and modulates interleukin 6 production by HEp-2 cells.
Topics: Anti-Infective Agents; Carcinoma; Chlamydia Infections; Chlamydophila pneumoniae; Hepatocytes; Human | 2003 |
[New achievements in the diagnosis and treatment of disseminated urogenital chlamydiosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; | 2003 |
Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Topics: Adult; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Dru | 2004 |
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneu | 2004 |
In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.
Topics: Anti-Infective Agents; Chlamydia Infections; Chlamydophila pneumoniae; Databases, Genetic; DNA, Bact | 2004 |
The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; Chlamydophila pneu | 2004 |
Management of acute epididymitis: are European guidelines being followed?
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Chlamydia Infections; C | 2004 |
[Clinical study of male urethritis in Oogaki Municipal Hospital].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chlamydia Infections; Fluoroquinolones; Gonorrhea; Hospita | 2005 |
Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells.
Topics: Aza Compounds; Cell Line; Cell Movement; Chemokine CCL2; Chlamydia Infections; Chlamydophila pneumon | 2005 |
Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; DNA Gyrase; | 2004 |
[Prevalence and treatment of pharyngeal Chlamydia trachomatis infections].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromy | 2006 |
Postoperative endophthalmitis caused by Bacillus cereus and Chlamydia trachomatis.
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Bacterial Agents; Bacillus cereus; Bacteri | 2007 |
[The combined therapy of patients with gonorrheal-chlamydial urogenital infections by leukinferon immunocorrection].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Chlamydia Infections; Cytokines; Doxycycline; Drug Combin | 1993 |
[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection].
Topics: Actihaemyl; Administration, Oral; Adolescent; Aged; Anti-Bacterial Agents; Anti-Infective Agents; An | 1997 |
In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Chlamydia Infections; Chlamydophila pne | 1998 |
Comparative in-vitro activity of levofloxacin against Chlamydia spp.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia; Chlamydia Infections; Humans; Levofloxacin; | 1998 |
National guideline for the management of non-gonococcal urethritis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases)
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlortetracycline; | 1999 |
National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Breast Feeding; Chlamydia Infecti | 1999 |
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; Chlamy | 2000 |
Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
Topics: Anti-Infective Agents; Chlamydia Infections; Chlamydophila pneumoniae; Community-Acquired Infections | 2000 |
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithro | 2000 |
In vitro and in vivo activities of sitafloxacin against Chlamydia spp.
Topics: Animals; Anti-Infective Agents; Chlamydia; Chlamydia Infections; Fluoroquinolones; Humans; Mice; Mic | 2001 |
[Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field].
Topics: Antibodies, Bacterial; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Dr | 2002 |
Updates on Chlamydia.
Topics: Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Erythromycin; Humans; Ofloxacin | 1992 |
Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin.
Topics: Acute Disease; Adult; Chlamydia Infections; Emergency Medical Services; Female; Follow-Up Studies; G | 1992 |
[Urogenital chlamydiosis].
Topics: Adult; Chlamydia Infections; Chronic Disease; Diagnosis, Differential; Female; Female Urogenital Dis | 1990 |
[Treatment of chlamydial urethritis--studies on clinical effects of ofloxacin].
Topics: Adult; Chlamydia Infections; Drug Evaluation; Humans; Male; Middle Aged; Ofloxacin; Urethritis | 1989 |
Ofloxacin in the treatment of gonococcal and chlamydial urethritis.
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Female; Gonorrhea; Humans; Male; Ofloxacin; Piva | 1988 |
[Studies of clinical efficacy of ofloxacin against male urethritis caused by Chlamydia trachomatis].
Topics: Adult; Aged; Chlamydia Infections; Chlamydia trachomatis; Drug Evaluation; Gonorrhea; Humans; Male; | 1988 |
[In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Topics: Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Female | 1988 |
The efficacy of ofloxacin against infection caused by Neisseria gonorrhoeae and Chlamydia trachomatis.
Topics: Chlamydia Infections; Chlamydia trachomatis; Female; Follow-Up Studies; Gonorrhea; Male; Ofloxacin | 1988 |
Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women.
Topics: Adolescent; Adult; Chlamydia Infections; Chlamydia trachomatis; Female; Genital Diseases, Female; Ge | 1988 |
[Ofloxacin for the treatment of chlamydial urethritis].
Topics: Adult; Antigens, Bacterial; Chlamydia Infections; Chlamydia trachomatis; Drug Evaluation; Humans; Im | 1988 |
[A study on the diagnosis and treatment of chlamydial infection of the conjunctiva].
Topics: Adult; Anti-Infective Agents; Chlamydia Infections; Conjunctivitis, Inclusion; Female; Humans; Infan | 1986 |
[Chlamydial conjunctivitis in adults].
Topics: Adult; Anti-Infective Agents; Chlamydia Infections; Conjunctivitis, Inclusion; Humans; Male; Ofloxac | 1986 |
[Neonatal ophthalmia due to chlamydial infection].
Topics: Anti-Infective Agents; Chlamydia Infections; Female; Humans; Infant, Newborn; Ofloxacin; Ophthalmia | 1986 |
Epididymitis: aspects concerning etiology and treatment.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Epididymitis; Humans; Mal | 1987 |
[Diagnosis of neonatal chlamydial infection by fluorescent antibody technique and its treatment with a new quinoline derivative].
Topics: Anti-Infective Agents; Chlamydia Infections; Conjunctivitis, Inclusion; Female; Fluorescent Antibody | 1986 |
[Treatment with ofloxacin (RU 43280) of uncomplicated bacterial urethritis in males].
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Gonorrhea; Humans; Male; | 1986 |